AtriCure Stock Earnings Reports
ATRC Upcoming Earnings (Q3 2023)
Earnings Date: | Nov 07, 2023 |
Consensus EPS: | Premium |
Current P/E* ratio: -72.28 | Price (Sep 29, 2023, EOD): $43.80
*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.
Last 2 Quarters for ATRC Premium
FAQ
About AtriCure
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.